Epidermal growth factor and growth hormone-releasing peptide-6: Combined therapeutic approach in experimental stroke

Restorative Neurology and Neuroscience

Volumn 31, Issue 2, 2013, Pages 213-223

  García Del Barco Herrera, Diana ^a   Martínez, Nelvys Subirós Mart́nez ^a   Coro Antich, Rosa María ^b   MacHado, Jorge Martín ^a   Alba, José Suárez ^a   Salgueiro, Sandra Rodríguez ^c   Acosta, Jorge Berlanga ^a  

^a Center of Pharmaceutical Chemistry Cuba   (Cuba)

^b CENTRO NACIONAL DE INFORMACIÓN DE CIENCIAS MÉDICAS   (Cuba)

^c NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

brain protection; combined therapy; EGF; GHRP6; global brain ischemia; neuroprotection; Stroke

Indexed keywords

EPIDERMAL GROWTH FACTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CIRCULUS ARTERIOSUS; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GAIT DISORDER; GERBIL; HISTOLOGY; HYPERACTIVITY; MALE; MUSCLE HYPOTONIA; NEUROPROTECTION; NONHUMAN; POSTERIOR COMMUNICATING ARTERY; PRIORITY JOURNAL;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CIRCLE OF WILLIS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; EPIDERMAL GROWTH FACTOR; GERBILLINAE; MALE; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 84876366867     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/RNN-120262     Document Type: Article

References (61)

1. Aberg, D. (2010). Role of the growth hormone/insulin-like growth factor 1 axis in neurogenesis. Endocr Dev, 17, 63-76.
2. Aguirre, A., Dupree, J.L., Mangin, J.M. & Gallo, V. (2007). A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci, 10(8), 990-1002. (Pubitemid 47185206)
3. Baldauf, K.&Reymann, K.G. (2005). Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia. Brain Res, 1056(2), 158-167. (Pubitemid 41557703)
4. Berlanga, J., Caballero, M.E., Ramirez, D., Torres, A., Valenzuela, C., Lodos, J. & Playford, R.J. (1998). Epidermal growth factor protects against carbon tetrachloride-induced hepatic injury. Clin Sci (Lond), 94(3), 219-223. (Pubitemid 28118982)
5. Berlanga, J., Cibrian, D., Guevara, L., Dominguez, H., Alba, J.S. & Seralena, A. et al. (2007). Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction. Clin Sci (Lond), 112(4), 241-50.
6. Berlanga, J., Lodos, J. & Lopez-Saura, P. (2002). Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents. Burns, 28(5), 435-42. (Pubitemid 34876873)
7. Brodie, C., Kentroti, S. & Vernadakis, A. (1991). Growth factors attenuate the cholinotoxic effects of ethanol during early neuroembryogenesis in the chick embryo. Int J Dev Neurosci, 9(3), 203-13.
8. Brywe, K.G., Leverin, A.L., Gustavsson, M., Mallard, C., Granata, R., Destefanis, S., Volante, M., Hagberg, H., Ghigo, E. & Isgaard, J. (2005). Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation. Endocrinology, 146(11), 4665-72. (Pubitemid 41447504)
9. Butterfield, J.D.&McGraw, C.P. (1978). Effect of DPPD (diphenylpara-phenylenediamine) on stroke and cerebral edema in gerbils. Stroke, 9(5), 480-83. (Pubitemid 8389077)
10. Caballero, M.E., Berlanga, J., Ramirez, D., Lopez-Saura, P., Gozalez, R. & Floyd, D.N., et al. (2001). Epidermal growth factor reduces multiorgan failure induced by thioacetamide. Gut, 48(1), 34-40. (Pubitemid 32042639)
11. Calapai, G., Marciano, M.C., Corica, F., Allegra, A., Parisi, A., Frisina, N., Caputi, A.P. & Buemi, M. (2000). Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol, 401(3), 349-56. (Pubitemid 30608719)
12. Casper, D. & Blum, M. (1995). Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture. J Neurochem, 65(3), 1016-26.
13. Cibrian, D., Ajamieh, H., Berlanga, J., Leon, O.S., Alba, J.S., Kim, M.J., Marchbank, T., Boyle, J.J., Freyre, F., Garcia Del, B.D., Lopez-Saura, P., Guillen, G., Ghosh, S., Goodlad, R.A.&Playford, R.J. (2006). Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clin Sci (Lond), 110(5), 563-73. (Pubitemid 43736119)
14. Clark, D.L., DeBow, S.B., Iseke, M.D. & Colbourne, F. (2003). Stress-induced fever after postischemic rectal temperature measurements in the gerbil. Can J Physiol Pharmacol, 81(9), 880-83. (Pubitemid 37188264)
15. Davis, D.P. & Patel, P.M. (2003). Ischemic preconditioning in the brain. Curr Opin Anaesthesiol, 16(5), 447-52. (Pubitemid 37297279)
16. Del Barco, D.G., Montero, E., Coro-Antich, R.M., Brown, E., Suarez-Alba, J., Lopez, L., Subiros, N. & Berlanga, J. (2011). Coadministration of epidermal growth factor and growth hormone releasing peptide-6 improves clinical recovery in experimental autoimmune encephalitis. Restor Neurol Neurosci.
17. Delgado-Rubin de Celix, A., Chowen, J.A. & Argente, J., Frago, L.M. (2006). Growth hormone releasing peptide-6 acts as a survival factor in glutamate-induced excitotoxicity. J Neurochem, 99(3), 839-49. (Pubitemid 44583443)
18. Delgado-Rubin, A., Chowen, J.A., Argente, J. & Frago, L.M. (2009). Growth hormone-releasing peptide 6 protection of hypothalamic neurons from glutamate excitotoxicity is caspase independent and not mediated by insulin-like growth factor I. Eur J Neurosci, 29(11), 2115-24.
19. Ehrenreich, H. Sireacuten, A.-L. (2001). Neuroprotection - what does it mean? - what means do we have? European Archives of Psychiatry and Clinical Neuroscience, 251, 149-51. (Pubitemid 32963491)
20. Fisher, M., Feuerstein, G., Howells, D.W., Hurn, P.D., Kent, T.A., Savitz, S.I. & Lo, E.H. (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke, 40(6), 2244-50.
21. Frago, L.M.&Chowen, J.A. (2005). Basic physiology of the growth hormone/insulin-like growth factor axis. Adv Exp Med Biol, 567, 1-25.
22. Frago, L.M., Paneda, C., Argente, J. & Chowen, J.A. (2005). Growth hormone-releasing peptide-6 increases insulin-like growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurones. J Neuroendocrinol, 17(11), 701-10. (Pubitemid 41555748)
23. Frago, L.M., Paneda, C., Dickson, S.L., Hewson, A.K., Argente, J.& Chowen, J.A. (2002). Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology, 143(10), 4113-22. (Pubitemid 35244390)
24. Gago, N., vellana-Adalid, V., Evercooren, A.B. & Schumacher, M. (2003). Control of cell survival and proliferation of postnatal PSA-NCAM(+) progenitors. Mol Cell Neurosci, 22(2), 162-78. (Pubitemid 36379181)
25. Ge, C., Yu, M., Petitte, J.N. & Zhang, C. (2009). Epidermal growth factor-induced proliferation of chicken primordial germ cells: Involvement of calcium/protein kinase C and NFKB1. Biol Reprod, 80(3), 528-36.
26. Gibson, E.M., Henson, E.S., Haney, N.,Villanueva, J.&Gibson, S.B. (2002). Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res, 62(2), 488-96. (Pubitemid 34106423)
27. Gibson, S.B. (2004). Epidermal growth factor and trail interactions in epithelial-derived cells. Vitam Horm, 67, 207-227. (Pubitemid 39753665)
28. Ginsberg, M.D. (2008). Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology, 55(3), 363-89.
29. Guan, J. (2008). Insulin-like growth factor-1 and its derivatives: Potential pharmaceutical application for ischemic brain injury. Recent Pat CNS Drug Discov, 3(2), 112-27.
30. Guo, S. & Lo, E.H. (2009). Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease. Stroke, 40(3 Suppl), S4-S7.
31. Hicks, D., Heidinger, V., Mohand-Said, S., Sahel, J. & Dreyfus, H. (1998). Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia. Gen Pharmacol, 30(3), 265-73. (Pubitemid 28046494)
32. Laidley, D.T., Colbourne, F. & Corbett, D. (2005). Increased behavioral and histological variability arising from changes in cerebrovascular anatomy of the Mongolian gerbil. Curr Neurovasc Res, 2(5), 401-407. (Pubitemid 41789606)
33. Lawner, P., Laurent, J., Simeone, F., Fink, E. & Rubin, E. (1979). Attenuation of ischemic brain edema by pentobarbital after carotid ligation in the gerbil. Stroke, 10(6), 644-47. (Pubitemid 10203454)
34. Lee, H., Bae, J.H. & Lee, S.R. (2004). Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res, 77(6), 892-900. (Pubitemid 39187072)
35. Limesand, K.H., Barzen, K.A., Quissell, D.O. & Anderson, S.M. (2003). Synergistic suppression of apoptosis in salivary acinar cells by IGF1 and EGF. Cell Death Differ, 10(3), 345-55. (Pubitemid 36582372)
36. Lo, E.H. (2008). Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol, 153 Suppl 1, S396-S405. (Pubitemid 351341004)
37. Lo, E.H., Moskowitz, M.A. & Jacobs, T.P. (2005). Exciting, radical, suicidal: How brain cells die after stroke. Stroke, 36(2), 189-192. (Pubitemid 40170779)
38. Lo, E.H.&Rosenberg, G.A. (2009). The neurovascular unit in health and disease: Introduction. Stroke, 40(3 Suppl), S2-S3.
39. Lo, E.H., Dalkara, T. & Moskowitz, M.A. (2003). Mechanisms, Challenges and Opportunities in Stroke. Nature Reviews Neuroscience, 4, 399-415. (Pubitemid 37280178)
40. Loskota,W.J., Lomax, P. & Rich, S.T. (1974). The gerbil as a model for the study of the epilepsies. Seizure patterns and ontogenesis. Epilepsia, 15(1), 109-19.
41. Macrez, R., Ali, C., Toutirais, O., Le, M.B., Defer, G., Dirnagl, U. & Vivien, D. (2011). Stroke and the immune system: From pathophysiology to new therapeutic strategies. Lancet Neurol, 10(5), 471-80.
42. Manninen, H., Makinen, K., Vanninen, R., Ronkainen, A. & Tulla, H. (2009). How often does an incomplete circle of Willis predispose to cerebral ischemia during closure of carotid artery? Postmortem and clinical imaging studies. Acta Neurochir (Wien.), 151(9), 1099-105.
43. Naylor, M., Bowen, K.K., Sailor, K.A., Dempsey, R.J. & Vemuganti, R. (2005). Preconditioning-induced ischemic tolerance stimulates growth factor expression and neurogenesis in adult rat hippocampus. Neurochem Int, 47(8), 565-72. (Pubitemid 41437901)
44. Niidome, T.,Morimoto, N., Iijima, S., Akaike, A., Kihara, T.&Sugimoto, H. (2006). Mechanisms of cell death of neural progenitor cells caused by trophic support deprivation. Eur J Pharmacol, 548(1-3), 1-8. (Pubitemid 44397004)
45. Ovbiagele, B., Kidwell, C.S., Starkman, S. & Saver, J.L. (2003). Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep, 3(1), 9-20. (Pubitemid 38898978)
46. Paneda, C., Arroba, A.I., Frago, L.M., Holm, A.M., Romer, J., Argente, J. & Chowen, J.A. (2003). Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats. Neuroreport, 14(12), 1633-35. (Pubitemid 37176842)
47. Peng, H.,Wen, T.C., Tanaka, J., Maeda, N., Matsuda, S.&Desaki, J., et al. (1998). Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries. J Cereb Blood Flow Metab, 18(4), 349-60. (Pubitemid 28166509)
48. Plahta, W.C., Clark, D.L. & Colbourne, F. (2004). 17beta-estradiol pretreatment reduces CA1 sector cell death and the spontaneous hyperthermia that follows forebrain ischemia in the gerbil. Neuroscience, 129(1), 187-93. (Pubitemid 39360954)
49. Rasband, W. (2006). ImageJ.(1.34s).
50. Seal, J.B., Buchh, B.N. & Marks, J.D. (2006). New variability in cerebrovascular anatomy determines severity of hippocampal injury following forebrain ischemia in the Mongolian gerbil. Brain Res, 1073-1074, 451-459.
51. Sheng, G., Guo, J. &Warner, B.W. (2007). Epidermal growth factor receptor signaling modulates apoptosis via p38alpha MAPKdependent activation of Bax in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol, 293(3), G599-G606. (Pubitemid 47435380)
52. Shuaib, A. & Hussain, M.S. (2008). The past and future of neuroprotection in cerebral ischaemic stroke. Eur Neurol, 59(1-2), 4-14. (Pubitemid 350277253)
53. Stroke Therapy Academic Industry Roundtable (STAIR) (1999). Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development. Stroke, 30(12), 2752-58.
54. Stummer, W., Weber, K., Tranmer, B., Baethmann, A. & Kempski, O. (1994). Reduced mortality and brain damage after locomotor activity in gerbil forebrain ischemia. Stroke, 25(9), 1862-69. (Pubitemid 24274985)
55. Traystman, R.J. (2010). Neuroprotection: Introduction. Stroke, 41(10 Suppl), S63.
56. Wakabayashi, K., Nagai, A., Sheikh, A.M., Shiota, Y., Narantuya, D.,Watanabe, T., Masuda, J., Kobayashi, S., Kim, S.U.&Yamaguchi, S. (2010). Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res, 88(5), 1017-25.
57. Woodruff, T.M., Thundyil, J., Tang, S.C., Sobey, C.G., Taylor, S.M. & Arumugam, T.V. (2011). Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener, 6(1), 11-29.
58. Yakovlev, A.G. & Faden, A.I. (2004). Mechanisms of neural cell death: Implications for development of neuroprotective treatment strategies. NeuroRx, 1(1), 5-16. (Pubitemid 46589338)
59. Yang, H., Liu, J., Wang, J.C., Liu, C.X., Sun, Y.Z., Han, G.Q., Gao, F.Y., Kang, C.S., Wang, H.Z. & Zhang, J.H. (2003). [Anatomical study and three dimensional image characteristic analysis of basicranial artery and its clinical significance]. Zhonghua Yi Xue Za Zhi, 83(1), 13-17.
60. Yu, J., Zeng, J., Cheung, R.T., Xiong, L., He, M., Liang, Z., Hong, H. & Huang, R. (2009). Intracerebroventricular injection of epidermal growth factor reduces neurological deficit and infarct volume and enhances nestin expression following focal cerebral infarction in adult hypertensive rats. Clin Exp Pharmacol Physiol, 36(5-6), 539-46.
61. Zheng, W.H., Kar, S., Dore, S. & Quirion, R. (2000). Insulin-like growth factor-1 (IGF-1): A neuroprotective trophic factor acting via the Akt kinase pathway. J Neural Transm. Suppl, (60), 261-72. (Pubitemid 32037198)